The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Triad hails recovery; Alpha Group profit tops outlook

Wed, 18th Jan 2023 14:54

(Alliance news) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

--------

Alpha Group International PLC - London-based provider of financial solutions - Expects 2022 revenue to increase by 27% to about GBP98 million, up from GBP77.5 million a year ago. Expects operating profit to be in line with expectations and pretax profit to be ahead. "These results have been achieved alongside increased investment in our people, infrastructure, and technology, in particular within our Alternative Banking Solutions division, where client demand continues to exceed our expectations," it explains.

--------

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Expects lower-than-expected revenue and significant back-end phasing of orders in financial 2023, but a stronger opening order book for financial 2024. Notes "several headwinds" impacting its ability to fulfil orders ahead of year-end on March 31. Says its current order book is GBP2.5 million, and further orders are expected, but says a number of orders will move into financial 2024. Full-year revenue from the Health & Nutrition business is now expected between GBP7.5 million to GBP8.0 million for the year ended March 31. This will result in a loss before interest, tax, depreciation and amortisation from continuing operations of around GBP1.0 million, Omega explains.

--------

STM Group PLC - London-based cross border financial services provider - Expects 2022 revenue to be GBP24.1 million. Earnings before interest, tax, depreciation and amortisation are expected to be no less than GBP3.2 million, with pretax profit to be not less than GBP1.7 million. "New business for the second half of the year remained steady albeit slower than anticipated, particularly within the personal pensions and life assurance business, and measures are being implemented to address this," it adds.

--------

Triad Group PLC - Godalming, England-based software and consultancy - Notes the "speed and vigour" of its recovery from "extraordinary" delays experienced for months during the summer of 2022. The Says it is now looking forward to a "very strong" fourth quarter. This will also likely be the basis for a "successful" following year.

--------

Crimson Tide PLC - Tunbridge Wells-based software developer - Says full-year revenue will exceed GBP5.3 million, up 30% from GBP4.1 million a year ago. "It is pleasing that the increased performance at the top line will result in a smaller-than-expected loss at the Ebitda level, despite the deployment of investment capital in marketing and growth," it says. Expects pretax loss to be smaller than expected due to "the enhanced sales figures and our decision to be cautious in marketing spend in the second half".

By Xindi Wei, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Jun 2014 10:10

UK WINNERS & LOSERS: Mining Companies Cheered By China PMI Data

Read more
23 Jun 2014 09:58

Omega Diagnostic Profit Up, Optimistic As It Ramps Up Visitect CD4 Commercialisation

Read more
23 Jun 2014 07:37

Omega Diagnostics' full-year results meet targets

- Adjusted pre-tax profit surges 41% - Strong performance from food intolerance division - Positive about future prospects Medical diagnostics company Omega reported a surge in full-year adjusted pre-tax profit after a robust performance from its food intolerance division and said it remains positi

Read more
14 Apr 2014 07:23

Omega Diagnostics Set To Meet Full Year Expectations

LONDON (Alliance News) - Omega Diagnostics Group PLC Monday said it had met market expectations for its last financial year, with revenues and adjusted pretax profit ahead of the previous year. The medical diagnostics company expects to post revenues of GBP11.6 million in the year to end-Ma

Read more
14 Apr 2014 07:15

UK MORNING BRIEFING: Glencore Sells Interest In Peru Copper Project

LONDON (Alliance News) - Glencore Xstrata said Monday it has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash. The deal is part of an agreement to w

Read more
24 Mar 2014 16:40

DIRECTOR DEALINGS: Omega Diagnostics Finance Director Buys Shares

LONDON (Alliance News) - Omega Diagnostics Group PLC said Monday that Finance Director Kieron Harbinson had bought 40,000 shares at 28.5 pence each. Following this transaction Harbinson's total share in the medical diagnostics products company is 0.33%. Shares in Omega closed down 0.9

Read more
5 Mar 2014 14:49

DIRECTOR DEALINGS: Omega Diagnostics Executives Buy Shares

LONDON (Alliance News) - Omega Diagnostics Group PLC Wednesday said Chief Executive Andrew Shepherd bought 18,000 shares at a price of 29.935 pence per share. Following this transaction, Shepperd holds 2.7 million shares, which represents a 2.46% stake in the firm. The company also sa

Read more
25 Feb 2014 11:11

Omega Diagnostics Gets Backdated Patent For CD4 Tests In 15 African States

LONDON (Alliance News) - Omega Diagnostics Group PLC said Tuesday that it had received a backdated patent for its CD4 test in 15 of the African Regional International Property Organisation States. The patent is valid from July 24, 2013. Omega produces Visitect CD4, a disposable, semi-

Read more
24 Feb 2014 13:50

UK MIDDAY BRIEFING: RSA Insurance, HSBC Lead FTSE 100 Lower

LONDON (Alliance News) - RSA Insurance is leading the FTSE 100 lower Monday after the struggling insurer confirmed it is considering a number of measures to bolster its balance sheet, while HSBC Holdings is also down after its results missed market forecasts.<

Read more
24 Feb 2014 11:42

UK WINNERS & LOSERS: Dixons, Carphone Warehouse Rise On Merger Talks

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Vodafone Group, up 6%. Vodafone's shares have jumped after the 6-for-11 consolidation of i

Read more
24 Feb 2014 09:57

Omega Diagnostics Shares Up On Grant, IDs-iSYS Project Progress

LONDON (Alliance News) - Shares in Omega Diagnostics Group PLC rose Monday after it announced that it had been granted a USD600,000 grant from Burnet Institute Melbourne and global health initiative UNITAID to build an assembly facility in India for its Visitect CD4 test. Shares in Omega we

Read more
24 Feb 2014 08:30

UK MORNING BRIEFING: HSBC Shares Fall On Lower-Than-Expected Profit

LONDON (Alliance News) - Shares have opened lower Monday amid a raft of UK corporate announcements. HSBC Holdings is the biggest faller in the FTSE 100, down 4.0%, as it reported just after the open lower-than-expected pretax profit in its recent full year.

Here is

Read more
13 Feb 2014 14:11

UK MIDDAY BRIEFING: Rolls-Royce, Tate & Lyle Weigh On FTSE 100

LONDON (Alliance News) - London's equity markets have focused on individual stocks Thursday after a plethora of earnings reports and trading updates, with Rolls-Royce Holdings and Tate & Lyle among the biggest losers after they cut guidance, and Im

Read more
13 Feb 2014 11:54

UK WINNERS & LOSERS: Tate & Lyle And Rolls Royce Guidance Disappoints

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.

-------

FTSE 100 - WINNERS

Imperial Tobacco Group, up 3.4%. The company has maintained its expecta

Read more
13 Feb 2014 11:20

Omega Diagnostics makes progress with HIV blood test

Shares in Omega Diagnostics rose after the medical group said it had passed a major milestone in developing its Visitect CD4 HIV blood test. The stock lifted 2.75p, or more than 16%, to 19.5p by 11:44 in London as Omega said it had completed the technology transfer phase for Visitect CD4, which ens

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account